MYCN and neuroblastoma: N-Myc gene amplification is an important clinical prognostic marker in neuroblastoma, and reducing N-Myc expression can induce neuroblastoma differentiation in vitro and may improve the prognosis of patients with N-Myc-amplified tumors [1,42-47].